Commentary on Surgery for metastatic urothelial carcinoma with curative intent: The German experience (AUO AB 30/05): Lehmann J, Suttmann H, Albers P, Volkmer B, Gschwend JE, Fechner G, Spahn M, Heidenreich A, Odenthal A, Seif C, Nürnberg N, Wülfing C, Greb C, Kälble T, Grimm MO, Fieseler CF, Krege S, Retz M, Schulte-Baukloh H, Gerber M, Hack M, Kamradt J, Stöckle M, Department of Urology, Städtisches Krankenhaus Kiel, Kiel, Germany; Department of Urology, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany

Autor: Grossman, H. Barton

Publikováno v: In Urologic Oncology: Seminars and Original Investigations 2009 27(3):339-339

Die Vereinigten Staaten von Amerika. Bd. 1: Geschichte – Politische Kultur – Politisches System – Wirtschaft. Bd. 2: Gesellschaft – Außenpolitik – Kultur – Religion – Erziehung W.P. Adams E.-O. Czempiel B. Ostendorf K.L. Shell P.B. Spahn M. Zöller

Autor: Schreyer, Söhnke

Publikováno v: Politische Vierteljahresschrift, 1992 Jun 01. 33(2), 361-364.

Externí odkaz: https://www.jstor.org/stable/24197830

Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers.

Autor: Olah C; Department of Urology, University of Duisburg-Essen, Essen, Germany., Mairinger F; Institute of Pathology, University Medicine Essen, University of Duisburg-Essen, Essen, Germany., Wessolly M; Institute of Pathology, University Medicine Essen, University of Duisburg-Essen, Essen, Germany., Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Spahn M; Department of Urology, University of Duisburg-Essen, Essen, Germany.; Lindenhofspital, Bern, Switzerland., Kruithof-de Julio M; Urology Research Laboratory, Department for BioMedical Research, University of Bern, Bern, Switzerland.; Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Hadaschik B; Department of Urology, University of Duisburg-Essen, Essen, Germany., Soós A; Department of Urology, Semmelweis University, Budapest, Hungary., Nyirády P; Department of Urology, Semmelweis University, Budapest, Hungary., Győrffy B; Research Centre for Natural Sciences, Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary.; Department of Bioinformatics, Semmelweis University, Budapest, Hungary., Reis H; Institute of Pathology, University Medicine Essen, University of Duisburg-Essen, Essen, Germany.; Dr. Senckenberg Institute of Pathology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany., Szarvas T; Department of Urology, University of Duisburg-Essen, Essen, Germany. tibor.szarvas@uk-essen.de.; Department of Urology, Semmelweis University, Budapest, Hungary. tibor.szarvas@uk-essen.de.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.

Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional Study.

Autor: Milonas D; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Urology, Lithuanian University of Health Sciences, Kaunas, Lithuania., Giesen A; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium., Muilwijk T; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Soenens C; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Devos G; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Venclovas Z; Department of Urology, Lithuanian University of Health Sciences, Kaunas, Lithuania., Briganti A; Department of Urology, University Vita Salute, San Raffaele Hospital, Milan, Italy., Gontero P; Department of Urology, University of Turin, A.O.U. San Giovanni Battista-le Molinette, Turin, Italy., Karnes RJ; Department of Urology, Mayo Clinic, Rochester, MN, USA., Chlosta P; Department of Urology, Jagiellonian University Medical College, Krakow, Poland., Claessens F; Laboratory of Molecular Endocrinology, KU Leuven, Leuven, Belgium., De Meerleer G; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium., Everaerts W; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Graefen M; Martini Klinik am UKE GmbH, Hamburg, Germany., Marchioro G; Department of Urology, University of Piemonte Orientale, Novara, Italy., Sanchez-Salas R; Department of Surgery, Division of Urology, McGill University, Montreal, Canada., Tombal B; Department of Urology, Cliniques Universitaires Saint Luc, Brussels, Belgium., Van Der Poel H; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Van Poppel H; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Spahn M; Department of Urology, Lindenhofspital Bern, Bern, Switzerland., Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Publikováno v: European urology open science [Eur Urol Open Sci] 2024 Jun 26; Vol. 66, pp. 33-37. Date of Electronic Publication: 2024 Jun 26 (Print Publication: 2024).

Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17.

Autor: Cathomas R; Division of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland., Rothschild SI; Department of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, Basel, Switzerland.; Department of Oncology/Hematology, Kantonsspital Baden, Baden, Switzerland., Hayoz S; Competence Center of SAKK, Bern, Switzerland., Bubendorf L; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Özdemir BC; Department of Oncology, Bern University Hospital, Bern, Switzerland., Kiss B; Department of Urology, Bern University Hospital, Bern, Switzerland., Erdmann A; Department of Oncology/Hematology, Kantonsspital Baden, Baden, Switzerland., Aeppli S; Department of Oncology, University Hospital HUG, Geneva, Switzerland., Mach N; Department of Oncology, Kantonsspital St Gallen, St Gallen, Switzerland., Strebel RT; Division of Urology, Kantonsspital Graubünden, Chur, Switzerland., Hadaschik B; Department of Urology, University Hospital Essen, Essen, Germany., Berthold D; Department of Oncology, University Hospital CHUV, Lausanne, Switzerland., John H; Department of Urology, Kantonsspital Winterthur, Winterthur, Switzerland., Zihler D; Department of Oncology, Kantonsspital Aarau, Aarau, Switzerland., Schmid M; Department of Oncology, Triemlispital, Zürich, Switzerland., Alborelli I; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Schneider M; Competence Center of SAKK, Bern, Switzerland., Musilova J; Competence Center of SAKK, Bern, Switzerland., Spahn M; Department of Urology, Bern University Hospital, Bern, Switzerland.; Hirslanden Klinik, Zürich, Switzerland.; Lindenhofspital Bern, Bern, Switzerland., Petrausch U; Onkozentrum Zürich, Zürich, Switzerland.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Nov 20; Vol. 41 (33), pp. 5131-5139. Date of Electronic Publication: 2023 Aug 17.